Longevity Health Holdings Inc focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania.
Show more...
FAQ
Longevity Health 今天的股價是多少?▼
XAGEW 目前價格為 $0 USD,過去 24 小時下跌了 -30.06%。在圖表上更密切關注 Longevity Health 股票的表現。
Longevity Health 的股票代號是什麼?▼
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,Longevity Health 的股票以代號 XAGEW 進行交易。
Longevity Health 的市值是多少?▼
今天 Longevity Health 的市值為 6,593.4
Longevity Health 去年的營收是多少?▼
Longevity Health 去年的營收為 100,000USD。
Longevity Health 去年的淨利是多少?▼
XAGEW 去年的淨收益為 -20.74MUSD。
Longevity Health 有多少名員工?▼
截至 April 07, 2026,公司共有 15 名員工。
Longevity Health 何時完成拆股?▼
Longevity Health 最近沒有進行任何拆股。
Longevity Health 的總部在哪裡?▼
Longevity Health 的總部位於 US 的 Pittsburgh。